Cargando…
Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor
The objective of this study was to investigate the platelet-to-lymphocyte ratio (PLR) in patients who underwent intravesical treatment for non-muscle invasive bladder cancer (NMIBC). A total of 197 patients who underwent intravesical Bacillus Calmette-Guerin treatment after transurethral resection o...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411071/ https://www.ncbi.nlm.nih.gov/pubmed/36034368 http://dx.doi.org/10.3389/fsurg.2022.907485 |
_version_ | 1784775238003720192 |
---|---|
author | Wu, Ruicheng Li, Dengxiong Zhang, Facai Bai, Yunjin Wang, Xiaoming Han, Ping |
author_facet | Wu, Ruicheng Li, Dengxiong Zhang, Facai Bai, Yunjin Wang, Xiaoming Han, Ping |
author_sort | Wu, Ruicheng |
collection | PubMed |
description | The objective of this study was to investigate the platelet-to-lymphocyte ratio (PLR) in patients who underwent intravesical treatment for non-muscle invasive bladder cancer (NMIBC). A total of 197 patients who underwent intravesical Bacillus Calmette-Guerin treatment after transurethral resection of bladder (TURB) were included. We divided the patients into different groups according to the treatment stage before and during induction treatment as Group 1 and Group 2, and set the change value of PLR as the Group 3. The cutoff values of PLR were determined through receiver operation characteristics curves analysis. we found a significant difference in recurrence-free survival (RFS) and progression-free survival (PFS) between patients with high serum PLR and those with low serum PLR in Group 1, as well as Group 2. Cox multivariate analysis revealed that tumor number ≥3, high grade, and history of carcinoma in situ (CIS) were significant factors predicting RFS and PFS. The PLR values before and during induction therapy could be used as predictors for the progression and recurrence of NMIBC patients receiving BCG immunotherapy. the PLR values after induction therapy have a stronger predictive power. |
format | Online Article Text |
id | pubmed-9411071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94110712022-08-27 Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Wu, Ruicheng Li, Dengxiong Zhang, Facai Bai, Yunjin Wang, Xiaoming Han, Ping Front Surg Surgery The objective of this study was to investigate the platelet-to-lymphocyte ratio (PLR) in patients who underwent intravesical treatment for non-muscle invasive bladder cancer (NMIBC). A total of 197 patients who underwent intravesical Bacillus Calmette-Guerin treatment after transurethral resection of bladder (TURB) were included. We divided the patients into different groups according to the treatment stage before and during induction treatment as Group 1 and Group 2, and set the change value of PLR as the Group 3. The cutoff values of PLR were determined through receiver operation characteristics curves analysis. we found a significant difference in recurrence-free survival (RFS) and progression-free survival (PFS) between patients with high serum PLR and those with low serum PLR in Group 1, as well as Group 2. Cox multivariate analysis revealed that tumor number ≥3, high grade, and history of carcinoma in situ (CIS) were significant factors predicting RFS and PFS. The PLR values before and during induction therapy could be used as predictors for the progression and recurrence of NMIBC patients receiving BCG immunotherapy. the PLR values after induction therapy have a stronger predictive power. Frontiers Media S.A. 2022-05-23 /pmc/articles/PMC9411071/ /pubmed/36034368 http://dx.doi.org/10.3389/fsurg.2022.907485 Text en Copyright © 2022 Wu, Li, Zhang, Bai, Wang and Han. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Surgery Wu, Ruicheng Li, Dengxiong Zhang, Facai Bai, Yunjin Wang, Xiaoming Han, Ping Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor |
title | Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor |
title_full | Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor |
title_fullStr | Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor |
title_full_unstemmed | Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor |
title_short | Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor |
title_sort | prognostic value of platelet-to-lymphocyte ratio in non-muscle invasive bladder cancer patients: intravesical bacillus calmette-guerin treatment after transurethral resection of bladder tumor |
topic | Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411071/ https://www.ncbi.nlm.nih.gov/pubmed/36034368 http://dx.doi.org/10.3389/fsurg.2022.907485 |
work_keys_str_mv | AT wuruicheng prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor AT lidengxiong prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor AT zhangfacai prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor AT baiyunjin prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor AT wangxiaoming prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor AT hanping prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor |